03 Apr The Evolution of Veterinary Cardiology: What’s Changed in the Last Decade
If your pet has been referred for a cardiac evaluation, it’s normal to wonder what that really means and whether anything has changed in recent years. The short answer is yes, quite a bit. Advancements in veterinary cardiology over the past decade have led to earlier diagnosis, more informed treatment decisions, and better long-term outcomes for many patients.
Earlier Detection of Heart Disease
One of the most meaningful changes has been the earlier detection of heart disease. This is not just due to better technology, but also stronger clinical evidence guiding when to intervene. A key example is the EPIC Study, which showed that starting pimobendan in certain dogs with mitral valve disease before the onset of congestive heart failure can delay progression. That study changed how we approach many cases and reinforced the importance of timing rather than waiting for more advanced disease.
The Role of Cardiac Testing and Imaging
In addition to imaging, blood-based cardiac markers such as NT-proBNP are now used more routinely. These tests can help determine whether signs like coughing or increased breathing effort are likely related to the heart. They are not used in isolation, but when combined with a physical exam and imaging, they can provide useful additional context.
Echocardiography remains the foundation of cardiac evaluation, but it has become more refined over time. Image quality, measurement consistency, and overall interpretation have improved, allowing for more confidence when identifying subtle or early changes. This is especially important in cases where decisions about monitoring versus starting medication are not always straightforward.
Advances in Monitoring and Treatment
Holter monitoring has also become much more practical. These devices, which record heart rhythm continuously over a day or longer, are now smaller and easier for pets to tolerate. Owners are able to manage them more comfortably at home, and the data can be analyzed more efficiently. This has made it easier to identify intermittent arrhythmias that might otherwise go undetected during a brief clinic visit.
While many of the medications used in cardiology have been available for years, how they are used has evolved. Pimobendan is the most obvious example, but more broadly, treatment of congestive heart failure has become more standardized and proactive. Medication plans are now more closely aligned with disease stage, and follow-up strategies are more structured. In addition, improvements in compounding and formulation options have made medications easier to administer, particularly for cats.
Breed-Specific Screening and Risk Awareness
There is also a greater emphasis on breed-specific screening. Certain breeds are known to be at higher risk for specific heart conditions, and screening recommendations have become more targeted as a result. For example, Doberman Pinschers are commonly monitored for dilated cardiomyopathy, while Cavalier King Charles Spaniels are predisposed to mitral valve disease. Identifying disease earlier in these patients allows for more appropriate monitoring and, when indicated, earlier treatment.
What Veterinary Cardiology Advancements Mean for Your Pet
Advancements in veterinary cardiology have shifted the focus from managing advanced heart disease to identifying problems earlier, monitoring them over time, and treating them at the most effective stage. With earlier detection, better data, and more thoughtful treatment strategies, many pets are living longer with stable disease and maintaining a good quality of life.
If your pet shows signs of a heart issue or needs a cardiac evaluation, contact Animal Cardiology Specialists of Nevada to schedule an appointment and get a clear plan for their care.
Photo by Nadia on Unsplash used with permission under the Creative Commons license for commercial use 04/03/2026